Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Virus (HCV)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00627926
What this trial is testing

Telaprevir in Combination With Pegasys® and Copegus® in Treatment-Naive Subjects With Genotype 1 Hepatitis C Virus (HCV)

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 1,095
Not applicableStudy completedNCT01945008
What this trial is testing

Observational Study in HCV Chronic Infection

Who this might be right for
Hepatitis C, Chronic
Istituto Superiore di Sanità 7,600
Post-approval studies (Phase 4)UnknownNCT04267458
What this trial is testing

Prevalence of Kidney Injury in Patients With HCV Treated With Sofuspovir Containing DAA Therapy

Who this might be right for
Investigate the Renal Effect of DAAs on Egyption Patients After Completion of Treatment
Cairo University 300
Not applicableUnknownNCT04039698
What this trial is testing

Monitoring of Hepatitis C Treatment Using Telemedicine - a Clinical Trial in Public Health System in Brazil

Who this might be right for
Chronic Hepatitis C
Hospital de Clinicas de Porto Alegre 144
Not applicableStudy completedNCT03246048
What this trial is testing

Long Term Follow-up of Hepatitis C Cured Patients

Who this might be right for
Chronic Hepatitis CChronic Liver DiseaseCirrhosis
Hospital Universitari Vall d'Hebron Research Institute 300
Large-scale testing (Phase 3)Study completedNCT04211909
What this trial is testing

Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir (SOF/VEL) Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX ) FDC for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 87
Large-scale testing (Phase 3)UnknownNCT02897596
What this trial is testing

Efficacy of GZR/EBR in Early Chronic Hepatitis C in HIV/HCV Co-infected Patients

Who this might be right for
Hepatitis CHIV
Fundacion Clinic per a la Recerca Biomédica 62
Testing effectiveness (Phase 2)Study completedNCT01464827
What this trial is testing

ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients

Who this might be right for
Chronic Hepatitis CHepatitis C (HCV)Hepatitis C Genotype 1
AbbVie (prior sponsor, Abbott) 580
Large-scale testing (Phase 3)Study completedNCT03074331
What this trial is testing

Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 130
Testing effectiveness (Phase 2)Study completedNCT02378961
What this trial is testing

Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Non-Genotype 1 HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 128
Not applicableStudy completedNCT03342261
What this trial is testing

Benefit of DAA Therapy in HCV Monoinfected and HIV-HCV Coinfected Patients With Mixed Cryoglobulinemia

Who this might be right for
Hepatitis C, ChronicMixed Cryoglobulinemia
Hospices Civils de Lyon 47
Testing effectiveness (Phase 2)Study completedNCT00120861
What this trial is testing

Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard Therapy

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC
Not applicableUnknownNCT04220151
What this trial is testing

Epigenetic Changes in Hepatocellular Carcinoma Developed After Direct Acting Antiviral Therapy for Chronic Hepatitis C

Who this might be right for
Hepatocellular Carcinoma
Assiut University 100
Testing effectiveness (Phase 2)Study completedNCT01987453
What this trial is testing

Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Participants With Chronic Genotype 1 HCV Who Participated in a Prior Gilead-Sponsored HCV Treatment Study

Who this might be right for
HCV Infection
Gilead Sciences 100
Testing effectiveness (Phase 2)Study completedNCT00085917
What this trial is testing

Peginterferon Alpha-2a and Ribavirin to Treat Hepatitis C in HIV-infected Patients

Who this might be right for
Hepatitis CHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 29
Testing effectiveness (Phase 2)Study completedNCT01057667
What this trial is testing

RO5024048 in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 1 or 4

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 168
Large-scale testing (Phase 3)Study completedNCT01500616
What this trial is testing

Telaprevir Open-Label Study in Co-Infected Patients

Who this might be right for
Hepatitis C, Chronic
Janssen-Cilag International NV 122
Large-scale testing (Phase 3)Study completedNCT02105701
What this trial is testing

Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With or Without Ribavirin for Participants With Hepatitis C Genotype 1, 4, or 6 Infections Who Have Failed Prior Treatment With Pegylated Interferon + Ribavirin (MK-5172-068)

Who this might be right for
Hepatitis C Infection
Merck Sharp & Dohme LLC 420
Early research (Phase 1)Study completedNCT01157104
What this trial is testing

A Drug-Drug Interaction Study Evaluating the Combination of IDX320 and IDX184 in Healthy Participants (MK-6844-002)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 20
Not applicableEnded earlyNCT02292706
What this trial is testing

A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 1,609
Next Page